ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Cogent Biosciences Inc

Cogent Biosciences Inc (COGT)

8.03
-0.15
(-1.83%)
Closed 15 February 8:00AM
8.03
0.00
( 0.00% )
Pre Market: 8:00PM

Cogent Biosciences Inc Financial Summary

The current COGT market cap is 887.01M. The company's latest EPS is USD -1.7419 and P/E is -1.35.

Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -59.58M-58.23M-62.4M-64.39M-75.41M
Net Income -55.38M-54.37M-58.35M-58.95M-70.63M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 22.5M7.87M000
Operating Income -32.18M-82.2M-75.55M-147.84M-208.13M
Net Income -31.83M-74.81M-72.27M-140.24M-192.41M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 355.45M313.44M476.11M429.94M384.02M
Total Liabilities 52.55M55.64M53.78M56.71M69.36M
Total Equity 302.9M257.8M422.33M373.22M314.66M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 49.42M250.92M232.09M300.81M313.44M
Total Liabilities 17.66M16.25M17.91M45.08M55.64M
Total Equity 31.76M234.67M214.18M255.74M257.8M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -109.55M-153.62M-52.53M-95.23M-147.21M
Investing -108.31M-97.82M1.04M-83.58M-23.4M
Financing 163.54M163.54M214.06M213.8M214.43M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -41.51M-35.85M-58.76M-118.64M-153.62M
Investing 23.16M8.42M-1.72M-124.72M-97.82M
Financing 108k232.2M37.98M163.56M163.54M
Market Cap 887.01M
Price to Earnings Ratio -1.35
Price to Sales Ratio 0
Price to Cash Ratio 4.88
Price to Book Ratio 1.01
Dividend Yield -

Share Statistics

Shares Outstanding 110.46M
Average Volume (1 week) 1.06M
Average Volume (1 Month) 1.4M
52 Week Change -8.96%
52 Week High 12.61
52 Week Low 5.73
Spread (Intraday) 1.61 (17.97%)

Company Info

Company Name Cogent Biosciences Inc
Address 838 walker road
dover, delaware 19904
Website https://www.unumrx.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock